137 related articles for article (PubMed ID: 33940949)
1. Identification of Heat Shock Protein 90 as a Recurrence Related Marker in Juvenile Nasopharyngeal Angiofibroma.
Wang J; Hu L; Liu Z; Wang H; Zhang H; Song X; Sun X; Wang D
Am J Rhinol Allergy; 2022 Jan; 36(1):8-17. PubMed ID: 33940949
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray analysis reveals that cofilin expression is a poor prognostic factor in juvenile nasopharyngeal angiofibroma.
Li W; Wang H; Yu H; Wang J; Song X; Liu Z; Liu J; Hu L; Li H; Wang D; Sun X
Int Forum Allergy Rhinol; 2019 Nov; 9(11):1273-1280. PubMed ID: 31623023
[TBL] [Abstract][Full Text] [Related]
3. Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance.
Wang JJ; Sun XC; Hu L; Liu ZF; Yu HP; Li H; Wang SY; Wang DH
Head Neck; 2013 Dec; 35(12):1719-25. PubMed ID: 23471755
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of matrix metalloproteinase 9 expression in patients with juvenile nasopharyngeal angiofibroma: tissue microarray analysis.
Sun X; Guo L; Wang J; Wang H; Liu Z; Liu J; Yu H; Hu L; Li H; Wang D
Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1232-8. PubMed ID: 24969348
[TBL] [Abstract][Full Text] [Related]
5. The presence of tumor-infiltrating IL-17-producing cells in juvenile nasopharyngeal angiofibroma tumor microenvironment is a poor prognostic factor.
Sun X; Guo L; Wang H; Yu H; Wang J; Meng X; Liu Z; Liu J; Hu L; Li H; Wang D
Am J Otolaryngol; 2014; 35(5):582-8. PubMed ID: 25014998
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-Inducible Factor-1α (HIF-1α) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis.
Song X; Yang C; Zhang H; Wang J; Sun X; Hu L; Liu Z; Wang D
Ann Otol Rhinol Laryngol; 2018 Jun; 127(6):357-366. PubMed ID: 29717655
[TBL] [Abstract][Full Text] [Related]
7. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis.
Liu Z; Wang J; Wang H; Wang D; Hu L; Liu Q; Sun X
Acta Otolaryngol; 2015 Jan; 135(1):51-7. PubMed ID: 25384380
[TBL] [Abstract][Full Text] [Related]
8. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma.
Saylam G; Yücel OT; Sungur A; Onerci M
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):227-34. PubMed ID: 16023739
[TBL] [Abstract][Full Text] [Related]
9. Juvenile nasopharyngeal angiofibroma: analysis of 42 cases and important aspects of endoscopic approach.
Midilli R; Karci B; Akyildiz S
Int J Pediatr Otorhinolaryngol; 2009 Mar; 73(3):401-8. PubMed ID: 19124161
[TBL] [Abstract][Full Text] [Related]
10. Juvenile nasopharyngeal angiofibroma: evaluation and surgical management of advanced disease.
Danesi G; Panciera DT; Harvey RJ; Agostinis C
Otolaryngol Head Neck Surg; 2008 May; 138(5):581-6. PubMed ID: 18439462
[TBL] [Abstract][Full Text] [Related]
11. Angiofibroma: an outcome review of conventional surgical approaches.
Hosseini SM; Borghei P; Borghei SH; Ashtiani MT; Shirkhoda A
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):807-12. PubMed ID: 15739087
[TBL] [Abstract][Full Text] [Related]
12. Cumulative sum analysis of the learning curve for endoscopic resection of juvenile nasopharyngeal angiofibroma.
Song X; Wang D; Sun X; Wang J; Liu Z; Liu Q; Gu Y
Surg Endosc; 2018 Jul; 32(7):3181-3191. PubMed ID: 29368283
[TBL] [Abstract][Full Text] [Related]
13. Recurrent juvenile nasopharyngeal angiofibroma treated with gamma knife surgery.
Park CK; Kim DG; Paek SH; Chung HT; Jung HW
J Korean Med Sci; 2006 Aug; 21(4):773-7. PubMed ID: 16891831
[TBL] [Abstract][Full Text] [Related]
14.
Sakthivel P; Kumar R; Arunraj ST; Bhalla AS; Prashanth A; Kumar R; Sharma SC; Thakar A
Laryngoscope; 2021 Jul; 131(7):1509-1515. PubMed ID: 33355921
[TBL] [Abstract][Full Text] [Related]
15. Bilateral juvenile nasopharyngeal angiofibroma: report of a case.
Wu EC; Chark DW; Bhandarkar ND
Int Forum Allergy Rhinol; 2014 Jul; 4(7):603-6. PubMed ID: 24664618
[TBL] [Abstract][Full Text] [Related]
16. Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study.
Zhang M; Sun X; Yu H; Hu L; Wang D
Acta Histochem; 2011 Oct; 113(6):626-30. PubMed ID: 20688360
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement.
Leong SC
Laryngoscope; 2013 May; 123(5):1125-31. PubMed ID: 23553370
[TBL] [Abstract][Full Text] [Related]
18. ROLE OF SURGICAL APPROACHES INFLUENCING TUMOUR RECURRENCE IN NASOPHARYNGEAL ANGIOFIBROMA.
Muhammad R; Hussain A; Rehman F; Iqbal J; Khan M; Ullah G; Khan Z
J Ayub Med Coll Abbottabad; 2015; 27(2):388-90. PubMed ID: 26411124
[TBL] [Abstract][Full Text] [Related]
19. The risk factors for residual juvenile nasopharyngeal angiofibroma and the usual residual sites.
Liu Z; Hua W; Zhang H; Wang J; Song X; Hu L; Lu H; Wang D
Am J Otolaryngol; 2019; 40(3):343-346. PubMed ID: 30885446
[TBL] [Abstract][Full Text] [Related]
20. Application of cyberknife for the treatment of juvenile nasopharyngeal angiofibroma: a case report.
Deguchi K; Fukuiwa T; Saito K; Kurono Y
Auris Nasus Larynx; 2002 Oct; 29(4):395-400. PubMed ID: 12393050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
